Company News

Share this article:

Sepracor moved creative duties for Lunesta from The Kaplan Thaler Group, a New York-based Publicis shop, to Lowe, an IPG shop, Adweek reported. Prior to The Kaplan Thaler Group, the creative account was handled by IPG's McCann HumanCare.

Bioniche Pharma, a manufacturer of specialty injectables, received a warning letter from DDMAC regarding web pages for Sotradecol (sodium tetradecyl sulfate injection) located on the Bioniche and AngioDynamics websites. The pages “fail to communicate any information about the risks associated with the product,” the letter stated. Bioniche was cited for the same violations in April of 2006. Sotradecol is indicated in the treatment of small, uncomplicated varicose veins.


Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.